SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-002369
Filing Date
2023-02-09
Accepted
2023-02-09 16:33:13
Documents
15
Period of Report
2023-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20230208.htm   iXBRL 8-K 75309
2 EX-4.1 sprb-ex4_1.htm EX-4.1 201078
3 EX-4.2 sprb-ex4_2.htm EX-4.2 201121
4 EX-10.1 sprb-ex10_1.htm EX-10.1 670008
  Complete submission text file 0000950170-23-002369.txt   1408377

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230208.xsd EX-101.SCH 2501
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230208_pre.xml EX-101.PRE 11578
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230208_lab.xml EX-101.LAB 18527
9 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230208_htm.xml XML 4901
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 23606754
SIC: 2834 Pharmaceutical Preparations